Journal article
Suyog U. Pol, Serena Liang, F. Schweser, Ravendra Dhanraj, A. Schubart, Marilena Preda, M. Sveinsson, D. Ramasamy, M. Dwyer, G. Weckbecker, R. Zivadinov
Experimental Neurology, 2020
Experimental Neurology, 2020
Semantic Scholar
DOI
PubMed
Cite
Cite
APA
Pol, S. U., Liang, S., Schweser, F., Dhanraj, R., Schubart, A., Preda, M., … Zivadinov, R. (2020). Subcutaneous anti-CD20 antibody treatment delays gray matter atrophy in human myelin oligodendrocyte glycoprotein-induced EAE mice. Experimental Neurology.
Chicago/Turabian
Pol, Suyog U., Serena Liang, F. Schweser, Ravendra Dhanraj, A. Schubart, Marilena Preda, M. Sveinsson, et al. “Subcutaneous Anti-CD20 Antibody Treatment Delays Gray Matter Atrophy in Human Myelin Oligodendrocyte Glycoprotein-Induced EAE Mice.” Experimental Neurology (2020).
MLA
Pol, Suyog U., et al. “Subcutaneous Anti-CD20 Antibody Treatment Delays Gray Matter Atrophy in Human Myelin Oligodendrocyte Glycoprotein-Induced EAE Mice.” Experimental Neurology, 2020.
